2009 Delegates
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
| A | |
|---|---|
| Abingworth | Managing Partner |
| Ablynx NV | Chief Executive Officer & Chairman of the Board |
| Acologix | President & CEO |
| ActoGenix NV | Chief Executive Officer |
| Addex Pharmaceuticals SA | Chief Executive Officer, Vice Chairman & Co-Founder |
| Aerie Pharmaceuticals Inc. | President & Chief Executive Officer |
| Affimed Therapeutics | Chief Executive Officer |
| Alta Partners | Managing Partner |
| AMRI | Chairman, President & Chief Executive Officer |
| Argos Therapeutics Inc. | Chief Executive Officer |
| Artisan Pharma | President & Chief Executive Officer |
| Ascendis Pharma | Chief Executive Officer |
| Astex Therapeutics | Chief Executive Officer |
| AstraZeneca | Director of Corporate Strategy & Head of VC Relations |
| AstraZeneca | Chief Executive Officer |
| Avanir Pharmaceuticals Inc. | President & Chief Executive Officer |
| Axentis Pharma AG | Advisor |
| B | |
| Biolex Therapeutics | President & Chief Executive Officer |
| BioMarin Pharmaceuticals | Chief Executive Officer |
| Biovertis AG | Chief Executive Officer |
| Bristol-Myers Squibb Company | Vice President, Head of Transactions |
| C | |
| Calistoga Pharmaceuticals Inc. | Chief Executive Officer |
| Cambridge Theranostics | Chief Executive Officer |
| Catalyst Biosciences | Chief Executive Officer |
| Cerenis Therapeutics SA | Chief Executive Officer |
| Clarus Ventures | Managing Director |
| Clinical Data Inc. | Chairman |
| Complete Genomics | Chief Executive Officer |
| Covington & Burling LLP | Partner, Co-Chair Life Sciences Industry Group |
| CSL Limited | Senior Vice President Corporate Development |
| CytRx Corporation | Vice President, Business Development |
| D | |
| Dance Pharmaceuticals | Chief Executive Officer & Founder |
| Deutsche Bank | Managing Director |
| Dicerna | Chief Executive Officer |
| E | |
| Edison Pharmaceuticals Inc. | Chairman & Chief Executive Officer |
| EGeen International Corporation | Chief Executive Officer |
| Eli Lilly and Company | President, European Operations |
| Eli Lilly and Company | Vice President or Corporate Finance and Investment Banking |
| Emergent BioSolutions | President |
| Endo Pharmaceuticals Inc. | Corporate Vice President, Corporate Development |
| Endotis Pharma | Chairman & Chief Executive Officer |
| EnVivo Pharmaceuticals Inc. | President & Chief Executive Officer |
| EOS SpA (Ethical Oncology Science) | Chief Executive Officer |
| ExonHit Therapeutics | Chief Executive Officer, President of the Management Board |
| F | |
| Ferring Pharmaceuticals A/S | President of The Executive Board & Chief Operating Officer |
| F Hoffmann La Roche Ltd | Mergers & Acquisitions, Member Roche Finance Executive Committee |
| FibroGen Inc. | Chairman, Founder, Chief Executive Officer |
| Flexion Therapeutics Inc. | Chief Executive Officer |
| FOVEA Pharmaceuticals | Co-Founder, Chief Executive Officer & Chairman of the Board |
| G | |
| Gilead Sciences | Senior Director, Corporate Development |
| GIMV N.V. | Executive Vice President Life Sciences |
| GlaxoSmithKline | Vice President APJEM R&D Business Development |
| GlaxoSmithKline | Vice President Transactions, Worldwide Business Development |
| GlaxoSmithKline | Vice President, Centre for Excellence for External Drug Discovery |
| GlaxoSmithKline | Vice President Worldwide Strategic Alliances & Business Development |
| GlobeImmune Inc. | President & Chief Executive Officer |
| GPC Biotech AG | President & Chief Executive Officer |
| I | |
| Imperial College Healthcare NHS Trust | Principal of the Faculty of Medicine & Chief Executive of Imperial College Healthcare NHS Trust |
| Imperial College Healthcare NHS Trust | Professor of Cardiology |
| Intra-Cellular Therapies Inc. | Chairman & Chief Executive Officer |
| Intrexon Corporation | Founder & Chief Science Officer |
| J | |
| Johnson & Johnson | Executive Vice President, Business Development, Pharmaceuticals Group |
| K | |
| Kiadis Pharma B.V. | Chief Executive Officer |
| L | |
| Lectus Therapeutics Limited | Chief Executive Officer |
| LifeCycle Pharma | President & Chief Executive Officer |
| M | |
| Marcadia BioTech | Chief Executive Officer |
| Medco Health Solutions | Chief Medical Officer |
| Merck Serono | Senior Director, Head of Merck Serono Ventures |
| Merck Sharpe & Dohme | Director |
| Movetis n.v. | Chief Executive Officer |
| N | |
| Neuropharm Group plc | Chief Executive Officer |
| NHS South Central | Chief Executive |
| Nitec Pharma | Chief Executive Officer |
| Novartis | Global Head of Mergers & Acquisitions |
| Novexel | Chief Executive Officer |
| NOXXON Pharma AG | Chief Executive Officer |
| O | |
| Orexo | Chief Executive Officer |
| Oxagen Limited | Chief Executive Officer |
| Oxford BioMedica plc | Chief Executive Officer |
| Oxford Bioscience Partners | Senior General Partner |
| P | |
| Pantarhei Bioscience | Supervisory Board Member |
| Paratek Pharmaceuticals Inc. | President & Chief Executive Officer |
| Pfizer Inc | Senior Vice President of New & International Business Development |
| Plexxikon Inc. | Founder & Chief Executive Officer |
| Poniard | Chairman & Chief Executive Officer |
| PregLem SA | Chief Executive Officer |
| PricewaterhouseCoopers | Partner, Pharmaceuticals & Life Sciences, Strategy |
| Probiodrug AG | Chief Financial Officer |
| Probiodrug AG | Chief Executive Officer |
| Prosensa Therapeutics BV | Chief Executive Officer |
| Prospect Venture Partners | Managing Director |
| Proteolix Inc. | Chief Executive Officer |
| Proteus Biomedical | President & Chief Executive Officer |
| Protherics | Former Chief Executive Officer |
| Q | |
| Qualcomm Incorporated | Vice President, Business Development, Health & Life Sciences |
| S | |
| sanofi-aventis | Senior Vice President, Business Development |
| Sciele Pharma Inc. | Chief Executive Officer |
| Scynexis | President & Chief Executive Officer |
| Sofinnova Partners | Partner |
| Solvay Pharmaceuticals | Financial Controller Global Commercial Operations |
| Sosei Group Corporation | Managing Director |
| SuppreMol GmbH | Chief Executive Officer |
| Syntaxin Ltd | Chief Executive Officer |
| T | |
| TaiGen Biotechnology Company Ltd | Chairman & Chief Executive Officer |
| Targacept Inc. | President & Chief Executive Officer |
| Tercica Inc. | Former Chief Executive Officer |
| Thrombogenics | Chief Executive Officer |
| Transave Inc. | President & Chief Executive Officer |
| TVM Capital GmbH | General Partner |
| TVM Capital GmbH | General Partner |
| Two Trees Consulting | President & Chief Executive Officer |
| U | |
| UCB S.A. | VP Corporate Business Development & Product Licensing |
| V | |
| Vitae Pharmaceuticals | Chief Executive Officer & President |
| Z | |
| Zealand Pharma A/S | Executive Vice President, Chief Operating Officer & Chief Financial Officer |
